We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 1BIIB market cap is 19.49B. The company's latest EPS is USD 11.1508 and P/E is 12.61.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.44B | 10.98B | 10.17B | 9.84B | 9.68B |
| Operating Income | 4.37B | 3.04B | 2.76B | 1.61B | 2.19B |
| Net Income | 4B | 1.81B | 3.05B | 1.16B | 1.63B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.62B | 23.88B | 24.55B | 26.84B | 28.05B |
| Total Liabilities | 13.93B | 12.92B | 11.17B | 12.05B | 11.33B |
| Total Equity | 10.69B | 10.96B | 13.39B | 14.8B | 16.72B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.23B | 3.64B | 1.38B | 1.55B | 2.88B |
| Investing | -608.6M | -563.7M | 1.58B | -4.1B | -799.2M |
| Financing | -5.27B | -2.09B | -1.75B | 149.3M | -683.5M |
| Market Cap | 19.49B |
| Price to Earnings Ratio | 12.61 |
| Price to Sales Ratio | 2.13 |
| Price to Cash Ratio | 8.67 |
| Price to Book Ratio | 1.23 |
| Dividend Yield | - |
| Shares Outstanding | 146.37M |
| Average Volume (1 week) | 24 |
| Average Volume (1 Month) | 53 |
| 52 Week Change | -34.86% |
| 52 Week High | 220.70 |
| 52 Week Low | 125.25 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Biogen Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.biogen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
